Jan-Michel Heger
14PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Mar 05, 2026
Glofitamab crosses the blood-brain barrier and exhibits activity against primary and secondary CNS lymphoma.Marie Anne-Catherine Neumann, Jessica Schneider, Max Szameitat
|Feb 09, 2026
MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay.Jan-Michel Heger, Julia Mattlener, Helen Kaul
|Jan 27, 2026
Rapid molecular response kinetics to anti-PD-1-based first-line treatment of Hodgkin lymphoma in the GHSG NIVAHL trial.Jan-Michel Heger, Julia Mattlener, Peter Herhaus
|Sep 30, 2024
Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma.Jan-Michel Heger, Laman Mammadova, Julia Mattlener
|Aug 14, 2024
Characteristics, outcomes and health care utilization of patients with acute myeloid leukemia aged 70 years or older: A single-center retrospective analysis.Marie Anne-Catherine Neumann, Jan-Hendrik Naendrup, Jorge Garcia Borrega
|Jun 27, 2024
Marked hyperferritinemia in critically ill cancer patients.Paul Liedgens, Jan-Michel Heger, Noelle Sieg
Pageof 3
Frequent Collaborators
5 joint publications
Jessica Schneider
4 joint publications
Julia Mattlener
4 joint publications
Michael J Hallek
4 joint publications
Bastian von Tresckow
3 joint publications
Dennis A Eichenauer
2 joint publications
Marie Anne-Catherine Neumann
2 joint publications
Boris Böll
2 joint publications
Paul J Bröckelmann
2 joint publications
Kerstin Becker
2 joint publications
Nadine Kutsch
